Research funding of 45 million!

On May 14, 2021, the launching ceremony of the "Innovation Research Institute Establishment and Academician Expert Workstation Unveiling" organized by Shanghai Zhongke New Life Biotechnology Co.

At the same time, there was an online live broadcast of the strategic partnership signing ceremony and the mass spectrometry multi-omics technology roundtable meeting

Established Zhongke New Life Innovation Research Institute

In the 17-year development history, Zhongke New Life has achieved a qualitative leap in its personnel scale and product service capabilities.

Academician Li Lin of the Chinese Academy of Sciences, Member of the Standing Committee of the Minhang District Committee of Shanghai, Deputy District Governor Guan Xiaojun, Professor Ding Chen of the Institute of Human Phenotype Group of Fudan University, Distinguished Professor Liu Sanhong of the Intersection Research Institute of Shanghai University of Traditional Chinese Medicine, Director of Shanghai Zhongke New Life President and General Manager Ms.

China Science New Life Academician Expert Workstation Unveiled

Liao Kan, Deputy Director of Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Ms.

Strategic partnership signing ceremony

At the event site, two well-known domestic biopharmaceutical companies visited the site and signed a strategic cooperation on the friendly cooperation between the two parties

A total of 45 million yuan has been invested to fund 2 "Fire Fighting Projects"

Zhongke New Life also released two blockbuster scientific research funding projects-the "Fire Program", which respectively solicited national cooperation projects in the multi-omics research of tumor clinical samples and the multi-omics research of traditional Chinese medicine

Fire Fighting Project: Multi-omics research support project for tumor clinical samples

Zhongke New Life will launch the "Multi-omics Research Support Plan for Tumor Clinical Samples" to promote the new development of tumor research through multi-omics technologies such as protein metabolism, and realize tumor prediction, prevention and precise treatment as soon as possible

The ribbon-cutting ceremony of the multi-omics research support project of tumor clinical samples of China Science New Life Fire Project

Fire Fighting Project: Multi-omics Research Support Project of Chinese Medicine

Zhongke New Life will launch the "Chinese Medicine Multi-omics Research Support Program".
The purpose of this program is to apply protein metabolism and other multi-omics technologies to further promote the progress of Chinese medicine research and contribute to the better application of Chinese medicine in clinical treatment
.
China Science New Life plans to invest a total of 15 million yuan in scientific research funds to solicit cooperative projects across the country within three years.
For the selected cooperative projects, Sino Science New Life will provide a minimum of 20% and a maximum of 50% of the project funding.
The funding content includes Scheme design, sample processing, mass spectrometry, data analysis and in-depth data mining
.

The ribbon-cutting ceremony of the Chinese Medicine Multi-omics Research Support Project

Roundtable: Discuss the development and challenges of multi-omics technology in mass spectrometry

Xie Yongming, deputy general manager of China Science and Technology New Life, chaired the first half round table meeting, Professor Ding Chen from the Institute of Human Phenotype Group of Fudan University, Professor Huang Chaolan, Director of the Precision Medicine Multi-omics Research Center of Peking University Health Science Center, and Li Shuijun, Laboratory of Shanghai Xuhui Central Hospital The director, Professor Zhan Xianquan of Shandong First Medical University, and Mr.
Tao Bo, the application support director of the Chromatography and Mass Spectrometry Division of Thermo Fisher Scientific China, shared the application prospects and challenges of multi-omics mass spectrometry technology in the clinical diagnosis and treatment of tumors.
Impressions
.

Roundtable: Prospects and Challenges for the Application of Mass Spectrometry Multi-omics Technology in Clinical Tumor Diagnosis and Treatment

Professor Huang Chaolan said: In the future, the proteomics society based on mass spectrometry will become more and more important
.
From my personal research work on tumor biomarkers, I have been able to find some markers through proteins
.
In the future, if conditions permit, protein should form an integrated and more accurate biomarker with upstream genes and downstream metabolism
.

Director Li Shuijun said: The potential of mass spectrometry is very large.
Mass spectrometry technology has been continuously tapped with our many previous studies.
Mass spectrometry is becoming more and more important for clinical diagnosis and clinical applications
.
But how to connect the data and results we made with mass spectrometry to the clinic is a challenge in the future
.

Ruan Hongqiang, deputy general manager of New Life, presided over the second half round table meeting.
Professor Liu Sanhong from Shanghai University of Traditional Chinese Medicine Interdisciplinary Research Institute, Professor Wu Jiarui, Deputy Director of Beijing University of Traditional Chinese Medicine Research Center for Chinese Medicine Pharmacovigilance and Rational Use, and Shanghai University of Traditional Chinese Medicine Shuguang Hospital Liver Disease Research Associate researcher Yang Tao and SCIEX China Application Technology Director Guo Lihai shared their experience and thoughts on the research and application prospects of mass spectrometry multi-omics technology in the field of Chinese medicine
.

Roundtable: Research and Application Prospects of Mass Spectrometry Multi-omics Technology in the Field of Traditional Chinese Medicine

Associate researcher Yang Tao said: Traditional Chinese medicine is a very complicated issue
.
Mass spectrometry is very extensive and very important in the field of traditional Chinese medicine, because the complexity of traditional Chinese medicine is very large
.
The material basis of traditional Chinese medicine is multi-layered.
How to control quality and control effectiveness is a big difficulty
.
Through mass spectrometry technology, we can carry out very accurate qualitative analysis of the components of traditional Chinese medicine
.

Professor Wu Jiarui said: In the context of life sciences and big data strategies, traditional Chinese medicine needs to be cross-integrated with life sciences, and traditional Chinese medicine pharmacology is the meeting point of traditional Chinese medicine and life sciences
.
From the perspective of research path, multi-omics, whether it is proteomics, transcriptome, genome, etc.
, and the fusion of traditional Chinese medicine, the pharmacological basis of traditional Chinese medicine and pharmacology, are important paths for the inheritance of traditional Chinese medicine
.
Multi-omics plays an important role in the inheritance and innovation of the theory and clinical practice of Chinese medicine
.

The launching ceremony of the establishment of the Innovation Research Institute of China Science and Technology New Life and the inauguration of the academician expert workstation was successfully concluded
.
China Science New Life has not only established a multi-omics joint analysis platform centered on the R&D and application of mass spectrometry technology, but also established a translational medicine and precision medical business platform driven by mass spectrometry data
.
Today, Zhongke New Life has established the Innovation Research Institute and Academician Expert Workstations, and hopes to further promote industry-university-research cooperation, introduce high-level talents, major project development, scientific and technological exchanges and achievements with the establishment of the Innovation Research Institute and Academician Expert Workstations.
There are new breakthroughs in conversion and other aspects
.
The Enterprise Innovation Research Institute will give full play to the supporting and leading role of the academician and expert team in enterprise innovation activities, integrate the resource advantages and independent innovation advantages of all parties, continue to deepen the cooperation mechanism of industry, university and research, and use this as an opportunity to accelerate the transformation of scientific and technological achievements.
Strive to become the R&D center and industrial base of China's life and health industry, leading and actively promoting the development of China's life and health industry!